We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.2B
AUM Growth
+$172M
(+0.43%)
Cap. Flow
-$1.31B
Cap. Flow
% of AUM
-3.26%
Top 10 Holdings %
Top 10 Hldgs %
18.88%
Holding
794
New
108
Increased
186
Reduced
363
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$427M |
| 2 |
RTN
Raytheon Company
RTN
|
+$193M |
| 3 |
RTX Corp
RTX
|
+$181M |
| 4 |
Marathon Petroleum
MPC
|
+$163M |
| 5 |
Deere & Co
DE
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$263M |
| 2 |
DuPont de Nemours
DD
|
+$238M |
| 3 |
Walmart Inc
WMT
|
+$216M |
| 4 |
Ross Stores
ROST
|
+$195M |
| 5 |
Fortive
FTV
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.26% |
| 2 | Technology | 15.21% |
| 3 | Financials | 12.82% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Industrials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
United Therapeutics
UTHR
$26.2B
| $11.7M | 0.03% |
+150,000
| New | +$14M |
|
502
Federal Realty Investment Trust
FRT
$10.7B
| $11.7M | 0.03% |
90,900
-100
| -0.1% | -$13.3K |
|
503
Amphenol
APH
$197B
| $11.7M | 0.03% |
487,652
+166,308
| +52% | +$4M |
|
504
Grocery Outlet
GO
$906M
| $11.5M | 0.03% |
+350,000
| New | +$10.8M |
|
|
XENT
505
DELISTED
Intersect ENT, Inc
XENT
| $11.4M | 0.03% |
500,000
+400,000
| +400% | +$10.8M |
|
506
Insulet
PODD
$11.5B
| $11.3M | 0.03% |
+95,000
| New | +$9.74M |
|
|
WRK
507
DELISTED
WestRock Company
WRK
| $11.3M | 0.03% |
310,289
+158,676
| +105% | +$5.83M |
|
508
Range Resources
RRC
$9.24B
| $11.2M | 0.03% |
1,600,000
-50,000
| -3% | -$434K |
|
|
JNPR
509
DELISTED
Juniper Networks
JNPR
| $11.2M | 0.03% |
418,900
+43,400
| +12% | +$1.16M |
|
510
Viatris
VTRS
$20.7B
| $11.2M | 0.03% |
585,871
-21,125
| -3% | -$467K |
|
|
ARNA
511
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $11.1M | 0.03% |
190,000
| – | – |
|
512
Graco
GGG
$13B
| $11M | 0.03% |
+219,589
| New | +$11.1M |
|
|
FARM
513
DELISTED
Farmer Brothers
FARM
| $11M | 0.03% |
+669,699
| New | +$12.8M |
|
514
Fox Class B
FOX
$22B
| $10.9M | 0.03% |
299,556
-456,633
| -60% | -$16.6M |
|
515
Constellium
CSTM
$3.89B
| $10.9M | 0.03% |
1,086,221
-463,438
| -30% | -$4.29M |
|
516
Incyte
INCY
$24.9B
| $10.9M | 0.03% |
127,952
-6,345
| -5% | -$509K |
|
517
Tradeweb Markets
TW
$20.8B
| $10.9M | 0.03% |
+247,894
| New | +$10.3M |
|
518
Brown-Forman Class B
BF.B
$13.2B
| $10.9M | 0.03% |
195,832
-10,400
| -5% | -$555K |
|
|
HSACU
519
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
| $10.8M | 0.03% |
+1,020,000
| New | +$10.6M |
|
520
Lamb Weston
LW
$7.36B
| $10.8M | 0.03% |
170,400
-9,200
| -5% | -$607K |
|
521
Packaging Corp of America
PKG
$22.2B
| $10.8M | 0.03% |
112,900
+2,700
| +2% | +$261K |
|
522
Ardelyx
ARDX
$1.25B
| $10.8M | 0.03% |
4,000,000
| – | – |
|
|
CBAY
523
DELISTED
Cymabay Therapeutics
CBAY
| $10.7M | 0.03% |
1,500,000
-925,000
| -38% | -$10.5M |
|
524
F5
FFIV
$22.1B
| $10.5M | 0.03% |
72,400
+14,800
| +26% | +$2.22M |
|
|
IPG
525
DELISTED
Interpublic Group of Companies
IPG
| $10.5M | 0.03% |
+464,034
| New | +$10.3M |
|
Similar funds
Adage Capital Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Adage Capital Partners held 794 positions worth $40.2B, up 0.43% from $40B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Adage Capital Partners withdrew a net $1.31B in Q2 2019, closing 91 positions and reducing 363 holdings. Its most notable exit was InflaRx, an estimated $85.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Raytheon Company worth $186M.
- Adage Capital Partners's largest Q2 2019 buy was Raytheon Company: 1,071,108 shares worth $186M.
- Adage Capital Partners added most to Celgene Corp in Q2 2019, an estimated $427M increase.
- Adage Capital Partners's biggest Q2 2019 reduction was Honeywell, cutting an estimated $263M.
- Adage Capital Partners fully exited InflaRx in Q2 2019, selling an estimated $85.9M.
- Adage Capital Partners's ten largest holdings make up 19% of its $40.2B portfolio in Q2 2019.
- Adage Capital Partners opened 108 new positions and closed 91 in Q2 2019.
- Adage Capital Partners's portfolio value rose 0.43% quarter-over-quarter to $40.2B.
Based on Adage Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.